Device Manufacturers Drive Education In China Amid Looming Tender Expansion
This article was originally published in PharmAsia News
China’s device market is poised for extraordinary growth with multinational firms such as Johnson & Johnson, Smith & Nephew and Stryker ramping up physician education against a backdrop of regulatory complexity and a possible new central tendering process.
You may also be interested in...
U.S.-listed orthopedic device maker Zimmer Inc. says its latest overseas purchase of Beijing Montagne Medical Device Co. Ltd., gives it greater marketing access to the Chinese orthopedic implant market, growing at an estimated 15 percent annually, and a manufacturing base to compete with rivals already in the market
After securing the first approval globally for an inhaled COVID-19 vaccine, Chinese biotech CanSino CEO Xuefeng Yu sat down with Scrip in this Chinese-language interview to share his views on vaccine development and market opportunities in China and elsewhere.
With the fourth quarter just around the corner, China's closely-watched annual drug reimbursement and prices negotiations are entering a key final stage. But will applicants need to be more strategic than expedient?